Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
BMJ Open|December 11, 2023
mHealth application for improving treatment outcomes for patients with multidrug-resistant tuberculosis in Vietnam: an economic evaluation protocol for the V-SMART trialQinglu Cheng, Tho Dang, Thu-Anh Nguyen, et al.
Eclinicalmedicine|April 8, 2024
Sustainability and impact of an intervention to improve initiation of tuberculosis preventive treatment: results from a follow-up study of the ACT4 randomized trialDick Menzies, Joseph Obeng, Panji Hadisoemarto, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|March 13, 2025
Synthesis of zinc oxide nano-rice decorated with silver nanoparticles for surface-enhanced Raman scattering (SERS) trace detection of isoprocarb and crystal violetSy Van Vu, Kim-Dung Thi Ho, Phuong-Thao Do, et al.
The Lancet Regional Health. Western Pacific|February 7, 2023
Mapping access to drug outlets in Vietnam: distribution of drug outlets and the sociodemographic characteristics of the communities they serveJustin Beardsley, Joshua Mark Chambers, Thanh Tuan Lam, et al.
Journal of Fungi (Basel, Switzerland)|November 21, 2020
Drug-Resistant <i>Aspergillus flavus</i> Is Highly Prevalent in the Environment of Vietnam: A New Challenge for the Management of Aspergillosis?Tra My N Duong, Phuong Tuyen Nguyen, Thanh Van Le, et al.
Journal of Infection and Public Health|September 8, 2025
Feasibility of an antimicrobial stewardship program in four district hospitals in VietnamJaslyn Doshi, Yen Ngoc Pham, Thuy Thu Ma, et al.
ERJ Open Research|October 27, 2022
Prevalence and genetic basis of first-line drug resistance of <i>Mycobacterium tuberculosis</i> in Ca Mau, VietnamJack Callum, Phuong T B Nguyen, Elena Martinez, et al.
BMJ Open|January 5, 2020
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trialGreg J Fox, Cam Binh Nguyen, Thu Anh Nguyen, et al.
The Lancet. Respiratory Medicine|March 29, 2024
High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trialRovina Ruslami, Federica Fregonese, Lika Apriani, et al.
Tropical Medicine & International Health : TM & IH|February 16, 2025
An mHealth app technology to strengthen adverse event management of multi-drug-resistant tuberculosis in Vietnam: Protocol for a process evaluation of the V-SMART trialBinh Hoa Nguyen, Tho T H Dang, Duy Trinh Hoang, et al.
Pageof 8